A Cohort Based Case Series: Learnings from an Iterative Group Therapy Model to Support Psilocybin-Assisted Therapy for Patients with a Terminal Diagnosis
European Psychiatry April 1, 2024 DOI: 10.1192/j.eurpsy.2024.791 via OpenAlex
Summary
AI-generated from the abstractA program offering weekly virtual group therapy sessions combined with a single psilocybin session helped patients with terminal health conditions. Twenty-one of twenty-five participants (84%) completed the program. Feedback highlighted improved preparation, benefits such as perspective and peace, the group as a key source of connection, and the need for a curriculum focused on death and loss. Psilocybin was delivered safely in a group setting, and the virtual community of practice supported set, setting, and integration.
Study at a glance
| Characteristics | Program development and quality improvement effort Case report Peer reviewed |
|---|---|
| Sample size | 25 |
| Population | Patients experiencing distress related to a terminal health condition |
| Intervention | Psilocybin-assisted therapy |
| Duration | One year |
| Keywords | Terminal diagnoses Unique support Help patients Supports patients Therapeutic journey |
| Key finding | Psilocybin can be delivered safely in a group setting, and a virtual community of practice is effective across set, setting, and integration. |
Abstract
Introduction While much is known about psilocybin-assisted therapy for individuals, little is known about the experience of participants in a group psilocybin therapy model. Objectives In an attempt to bridge this gap in the literature, a program development and quality improvement effort was launched. Methods Thirty-one psychedelic-assisted therapy (PaT) sessions were provided for 25 participants within four iterative cohorts over the span of one year. This article reports participant feedback in an effort to inform the benefits and challenges of group-administered PaT. Results Six to eight once-weekly group resilience-based community of practice (CoP) sessions were combined with one psilocybin-assisted therapy session for patients experiencing distress related to a terminal health condition. The virtual hybrid group therapy model is research informed, with a curriculum that provides knowledge-based content, combined with the relational elements necessary to successfully deliver group-administered psilocybin-assisted therapy. Twenty one of the twenty five participants (84%) completed the program. Based on participant feedback, the following themes emerged: 1) Improvement of pre-treatment preparation sessions; 2) PaT Benefits: Gaining perspective, peace, non-attachment, authenticity, honesty, relational capacity; 3) The community of practice (CoP) as the primary conduit for connection and regulation 4) Population specific curriculum with a greater focus on how to navigate death, pain and loss; 5) PaT session Challenges; 6) The interpersonal and support capacity of the team as critical for the overall experience. Conclusions While more research is needed, results suggest that psilocybin can be delivered safely in a group setting, and that a virtual CoP is effective across the spectrum of set, setting and integration Our findings also suggest that there is much to learn - and improve upon - in this novel area of service delivery. Disclosure of Interest None Declared